Final Demonstration of the Co-Identity of Lipiarmycin A3 and Tiacumicin B (Fidaxomicin) through Single Crystal X-ray Analysis
暂无分享,去创建一个
[1] G. Lancini,et al. Lipiarmycin, a new antibiotic from Actinoplanes. II. Isolation, chemical, biological and biochemical characterization. , 1975, The Journal of antibiotics.
[2] F. Parenti,et al. LIPIARMYCIN, A NEW ANTIBIOTIC FROM ACTINOPLANES , 1975 .
[3] F. Parenti,et al. Lipiarmycin, a new antibiotic from Actinoplanes. I. Description of the producer strain and fermentation studies. , 1975, The Journal of antibiotics.
[4] R. White,et al. Lipiarmycin, a new antibiotic from Actinoplanes III. Mechanism of action. , 1975, The Journal of antibiotics.
[5] H. Flack,et al. On enantiomorph‐polarity estimation , 1983 .
[6] E. Martinelli,et al. Structural studies on lipiarmycin. I. Characterization by 1H and 13C NMR spectroscopy and isolation of methyl 2-O-methyl-4-O-homodichloroorsellinate-beta-rhamnoside. , 1983, The Journal of antibiotics.
[7] S. Ōmura,et al. Clostomicins, new antibiotics produced by Micromonospora echinospora subsp. armeniaca subsp. nov. I. Production, isolation, and physico-chemical and biological properties. , 1986, The Journal of antibiotics.
[8] B. Cavalleri,et al. Structure elucidation of the macrocyclic antibiotic lipiarmycin , 1987 .
[9] R. J. Theriault,et al. Tiacumicins, a novel complex of 18-membered macrolide antibiotics. I. Taxonomy, fermentation and antibacterial activity. , 1987, The Journal of antibiotics.
[10] B. Cavalleri,et al. Structure and biological activity of lipiarmycin B. , 1988, The Journal of antibiotics.
[11] P. Fernandes,et al. In vitro and in vivo evaluation of tiacumicins B and C against Clostridium difficile , 1991, Antimicrobial Agents and Chemotherapy.
[12] Maria Cristina Burla,et al. SIR97: a new tool for crystal structure determination and refinement , 1999 .
[13] T. Dick,et al. Lipiarmycin targets RNA polymerase and has good activity against multidrug-resistant strains of Mycobacterium tuberculosis. , 2008, Journal of Antimicrobial Chemotherapy.
[14] Jason W. Lancaster,et al. Fidaxomicin: the newest addition to the armamentarium against Clostridium difficile infections. , 2012, Clinical therapeutics.
[15] W. Erb,et al. From natural product to marketed drug: the tiacumicin odyssey. , 2013, Natural product reports.
[16] D. Nathwani,et al. Clinical efficacy of fidaxomicin compared with vancomycin and metronidazole in Clostridium difficile infections: a meta-analysis and indirect treatment comparison. , 2014, The Journal of antimicrobial chemotherapy.
[17] C. Fuganti,et al. The Co-identity of Lipiarmycin A3 and Tiacumicin B , 2014, Natural product communications.
[18] K. Gademann,et al. Total synthesis of the protected aglycon of fidaxomicin (tiacumicin B, lipiarmycin A3). , 2015, Angewandte Chemie.
[19] K. Gademann,et al. Total Synthesis of the Glycosylated Macrolide Antibiotic Fidaxomicin. , 2015, Organic letters.
[20] K. Altmann,et al. Total synthesis of the tiacumicin B (lipiarmycin A3/fidaxomicin) aglycone. , 2015, Angewandte Chemie.
[21] W. Erb,et al. Enantioselective synthesis of putative lipiarmycin aglycon related to fidaxomicin/tiacumicin B. , 2015, Angewandte Chemie.
[22] V. Fíla,et al. Experimental crystal structure determination , 2016 .